Patents Assigned to Vanda Pharmaceutials Inc.
  • Methods for the administration of iloperidone
    Patent number: 12606869
    Abstract: The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
    Type: Grant
    Filed: April 8, 2022
    Date of Patent: April 21, 2026
    Assignee: Vanda Pharmaceutials Inc.
    Inventors: Curt Wolfgang, Mihael Polymeropoulos, Christian Lavedan, Simona Volpi